Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

One Agricultural Chemicals Stock Trading Near Resistance Levels – NTR

Dec 16, 2025 | Team Kalkine
One Agricultural Chemicals Stock Trading Near Resistance Levels – NTR
Image source: shutterstock

  • NTR:NYSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

This report is an updated version of the report published on December 16, 2025 at 2:02 AM EST

Nutrien Ltd. (NYSE: NTR)

Nutrien Ltd. (NYSE: NTR) is a global provider of crop inputs and services. It operates a network of production, distribution and ag retail facilities.

Recommendation Rationale – Sell at USD 61.85 

  • With respect to the Crop Nutrient Markets, NTR stated that it expects 2% growth in global nitrogen demand in 2025 as well as supply related challenges to maintain tight supply and demand balance moving forward 2026. Notably, global ammonia markets are anticipated to remain tight because of the plant outages and project delays. The company expects that the pace of Chinese urea exports would be slowing down in Q4 FY 2025. The emergence of seasonal demand is anticipated to support market fundamentals.
  • NTR is exposed to the risks related to the seasonality, climate change and weather conditions, which include the impacts from regional flooding and/or drought conditions.
  • Also, changes in government policy can also impact NTR’s results of operations.
  • The company’s share price surpassed its R1 level recommended on November 4, 2025. Therefore, there can be a possible decline from the specified resistance levels. 

NTR’s Daily Price Chart

Fundamental Valuation

Considering the increasing volatility over global equity market, inflationary pressures, geopolitical tensions, etc. the company’s stock might trade at slight discount. For the valuation, peers such as CF Industries Holdings Inc (NYSE: CF), Mosaic Co (NYSE: MOS), etc. were considered.  

Given its current trading levels, and risks associated, it is prudent to book profit at the current levels.

Hence, a ‘Sell’ rating has been provided on the stock at the closing price of USD 61.85 per share, down by 1.58% as on December 15, 2025

Nutrien Ltd. (NYSE: NTR) is part of Kalkine’s Global Agriculture Report. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical issues prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing. 

Note 1: Past performance is neither an indicator nor a guarantee of future performance. 

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 15 December 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above. 

Note 4: Kalkine reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice. 

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.  

Resistance: A level at which the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest. 

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions